Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Omega-3 polyunsaturated fatty acids in the treatment of kidney disease.

Fassett RG, Gobe GC, Peake JM, Coombes JS.

Am J Kidney Dis. 2010 Oct;56(4):728-42. doi: 10.1053/j.ajkd.2010.03.009. Epub 2010 May 20. Review.

PMID:
20493605
2.
3.

The role of fish oil/omega-3 fatty acids in the treatment of IgA nephropathy.

Donadio JV, Grande JP.

Semin Nephrol. 2004 May;24(3):225-43. Review.

PMID:
15156528
4.

Is body size a biomarker for optimizing dosing of omega-3 polyunsaturated fatty acids in the treatment of patients with IgA nephropathy?

Donadio JV, Bergstralh EJ, Bibus DM, Grande JP.

Clin J Am Soc Nephrol. 2006 Sep;1(5):933-9. Epub 2006 Aug 2.

5.

Usefulness of omega-3 fatty acids and the prevention of coronary heart disease.

Harper CR, Jacobson TA.

Am J Cardiol. 2005 Dec 1;96(11):1521-9. Epub 2005 Oct 21.

PMID:
16310434
6.

[Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].

Banković-Calić N, Ogbori MR, Nicman E.

Srp Arh Celok Lek. 2002 Jul-Aug;130(7-8):251-7. Serbian.

PMID:
12585002
7.

Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials.

Filion KB, El Khoury F, Bielinski M, Schiller I, Dendukuri N, Brophy JM.

BMC Cardiovasc Disord. 2010 Jun 3;10:24. doi: 10.1186/1471-2261-10-24. Review.

8.

n-3 polyunsaturated fatty acids: update 1995.

Endres S, De Caterina R, Schmidt EB, Kristensen SD.

Eur J Clin Invest. 1995 Sep;25(9):629-38. Review.

PMID:
7498235
9.

Omega-3 fatty acids in inflammation and autoimmune diseases.

Simopoulos AP.

J Am Coll Nutr. 2002 Dec;21(6):495-505. Review.

PMID:
12480795
10.

Omega-3 long-chain polyunsaturated fatty acids supplementation on inflammatory biomakers: a systematic review of randomised clinical trials.

Rangel-Huerta OD, Aguilera CM, Mesa MD, Gil A.

Br J Nutr. 2012 Jun;107 Suppl 2:S159-70. doi: 10.1017/S0007114512001559. Review.

PMID:
22591890
12.

A randomized trial of high-dose compared with low-dose omega-3 fatty acids in severe IgA nephropathy.

Donadio JV Jr, Larson TS, Bergstralh EJ, Grande JP.

J Am Soc Nephrol. 2001 Apr;12(4):791-9.

13.

N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials.

Bucher HC, Hengstler P, Schindler C, Meier G.

Am J Med. 2002 Mar;112(4):298-304.

PMID:
11893369
14.

Omega-3 polyunsaturated fatty acids and cardiovascular diseases.

Lavie CJ, Milani RV, Mehra MR, Ventura HO.

J Am Coll Cardiol. 2009 Aug 11;54(7):585-94. doi: 10.1016/j.jacc.2009.02.084. Review.

15.

The fats of life: the role of omega-3 fatty acids in the prevention of coronary heart disease.

Harper CR, Jacobson TA.

Arch Intern Med. 2001 Oct 8;161(18):2185-92.

PMID:
11575974
16.

Effect of fish oil on oxidative stress, lipid profile and renal function in IgA nephropathy.

Parinyasiri U, Ong-Ajyooth L, Parichatikanond P, Ong-Ajyooth S, Liammongkolkul S, Kanyog S.

J Med Assoc Thai. 2004 Feb;87(2):143-9.

PMID:
15061297
17.

Omega-3 fatty acids and risk of cognitive impairment and dementia.

Laurin D, Verreault R, Lindsay J, Dewailly E, Holub BJ.

J Alzheimers Dis. 2003 Aug;5(4):315-22.

PMID:
14624027
18.

Omega-3 fatty acids: role in cardiovascular health and disease.

Engler MM, Engler MB.

J Cardiovasc Nurs. 2006 Jan-Feb;21(1):17-24, quiz 25-6. Review.

PMID:
16407732
19.

Omega-3 fatty acids in health and disease and in growth and development.

Simopoulos AP.

Am J Clin Nutr. 1991 Sep;54(3):438-63. Review.

PMID:
1908631
20.

Omega-3 polyunsaturated fatty acids: a potential new treatment of immune renal disease.

Donadio JV Jr.

Mayo Clin Proc. 1991 Oct;66(10):1018-28. Review.

PMID:
1921484

Supplemental Content

Support Center